 | Up a level |
Singh, Sneha and Kumar, B Vikram and Jitender, and Mishra, Pranaya M and Verma, Geetika and Kumar, Sahil and Pandit, Suvechchha and Kumar, Reetesh and Ringe, Rajesh P and Tripathi, Shashank and Gupta, Nimesh and Mishra, Ravi P N (2024) Scalable bioprocess for high-yield production of SARS-CoV-2 trimeric spike protein-based immunogen (IMT-CVAX) using suspension CHO cells. Process Biochemistry, 147. pp. 332-346.
Jitender} and Vikram Kumar, B and Singh, Sneha and Verma, Geetik, and Bhardwaj, Ashwani K and Mankotia, Dhananjay S and Ringe, Rajesh P and Gupta, Nimesh and Tripathi, Shashank and Mishra, Ravi P N (2024) Mammalian cell expressed recombinant trimeric spike protein is a potent vaccine antigen and confers near-complete protection against SARS-CoV-2 infection in Hamster. Vaccine, 42 (20). p. 126099.
